Back to Dashboard
MDXG · Healthcare

MIMEDX GROUP INC

USA Healthcare Filing: 2025-12-31
Smart-money confidence · 1 of 3 sources firing
Bearish — money moving out

No standout activity across the feeds we track.

Hedge funds
26
Congress
No data
Insiders
No data
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s.  ·  how the score works
◆ Next steps Interested in MIMEDX GROUP INC? Here's what to do with it.
Not financial advice. Bogen Capital surfaces public SEC filings — you decide what to do with them.
Market cap
$635M
Industry
Biotechnology
Sector
Healthcare
Exchange
NasdaqCM
About MIMEDX GROUP INC

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company processes the human placental tissues membrane, and umbilical cord and the placental disc utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins, including cytokines, chemokines, and growth factors. Its patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. The company's wound care products include EPIFIX,…

Who's behind the signal
Every informed buyer we can see on MDXG, across all three feeds.
Hedge funds · 5
Point72 (Steve Cohen) New position
Citadel Advisors Increased +228%
D.E. Shaw & Co Decreased −43%
AQR Capital Management Decreased −25%
Congress · 0
No congressional trades on record.
Insiders
No significant Form 4 insider activity in the window.
Not a model pick — but on our radar. MIMEDX GROUP INC isn't in the top-10 model right now, but 5 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
5
Investors
1
New positions
1
Increasing
3
Decreasing
0
Unchanged
Price History
Loading price data...
Return: High: Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Trust weight: 1.1×
New position
% of portfolio
0.0%
Position change
NEW
0.0% of Point72's portfolio
Trust weight: 1.0×
Increased +228%
% of portfolio
0.0%
Position change
+228%
0.0% of Citadel Advisors's portfolio
Trust weight: 1.0×
Decreased −43%
% of portfolio
0.0%
Position change
−43%
0.0% of D.E. Shaw & Co's portfolio
Trust weight: 1.0×
Decreased −25%
% of portfolio
0.0%
Position change
−25%
0.0% of AQR Capital Management's portfolio
Trust weight: 1.0×
Decreased −46%
% of portfolio
0.0%
Position change
−46%
0.0% of Millennium Management's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to MIMEDX GROUP INC
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell MIMEDX GROUP INC or any security.

Get the Weekly Update

Every Sunday, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime